'Test to Treat' gets COVID pills to at-risk patients fast but its reach is limited

The Biden administration's new program enables high-risk patients who test positive to get antiviral pills on the spot in some pharmacies. But many pharmacies won't be able to participate.

Related Keywords

Wayne State University ,Michigan ,United States ,South Carolina ,White House ,District Of Columbia ,University Of South Carolina ,Americans ,American ,Susan Davis ,Michael Ganio ,Julie Ann Justo ,Cameron Webb ,Natalie Quillian ,James Hildreth ,Society Of Infectious Disease Pharmacists ,Veterans Affairs ,American Society Of Health ,Pfizer ,American Medical Association ,Kaiser Health News ,University Of South Carolina College Pharmacy ,Meharry Medical College ,Ridgeback Pharmaceuticals ,Celine Gounder ,Kaiser Health ,American Society ,Health System Pharmacists ,Minute Clinics ,South Carolina College ,Infectious Disease Pharmacists ,